Boardroom Alpha
Boardroom Alpha
ACON · Current Report (Form 8-K) · Filed July 21, 2025

Aclarion Inc — Current Report (Form 8-K)

Form
8-K
Filed
July 21, 2025
Period
Jul 21, 2025
Ticker
ACON
Accession
0001683168-25-005246
Boardroom Alpha · Filing insights

Seven directors were elected for 2026. The reverse stock split was approved; the equity incentive plan amendment was not.

About Aclarion Inc
Market cap
$9M
1Y TSR
−54.3%
3Y TSR
−97.2%
Board grade
D
Sector
Healthcare
CEO
Brent Ness
Last annual meeting: Jun 4, 2026 · View full Aclarion Inc profile →
Aclarion, Inc. 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 21, 2025

 

 

 

Aclarion, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware 001-41358 47-3324725
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

 

8181 Arista Place, Suite 100  
Broomfield, Colorado 80021
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (833) 275-2266

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

  Trading  
Title of each class Symbol(s) Name of each exchange on which registered
Common Stock ACON Nasdaq Stock Market
Common Stock Warrants ACONW Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

   

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On July 21, 2025, the Company reconvened and held its 2025 Annual Meeting of Stockholders. The Annual Meeting had been adjourned from the original scheduled meeting date of July 7, 2025.

 

The matters voted upon at the Annual Meeting and the results of such voting are set forth below.

 

Proposal 1 - Election of seven directors to serve a term ending at the 2026 annual meeting, in each case until their respective successors are duly elected and qualified.

 

Nominee  Votes For  Withheld  Broker Non-Votes
Jeffrey Thramann   51,347    15,267    200,431 
Brent Ness   47,840    18,774    200,431 
Stephen Deitsch   47,374    19,240    200,431 
Scott Breidbart   50,170    16,444    200,431 
David Neal   49,956    16,658    200,431 
William Wesemann   49,902    16,713    200,431 
Amanda Williams   50,244    16,370    200,431 

 

All seven director nominees were duly elected.

 

 

Proposal 2 - Ratification of appointment of independent registered accounting firm – Haynie & Company

 

Votes For  Votes Against  Abstain  Broker Non-Votes
 241,005    23,143    2,898    0 

 

Proposal 2 was approved.

 

 

Proposal 3 – Approval of a proposed reverse stock split

 

Votes For  Votes Against  Abstain  Broker Non-Votes
 177,593    87,330    2,124    0 

 

Proposal 3 was approved.

 

 

Proposal 4 – Approval of an amendment to our 2022 equity incentive plan

 

Votes For  Votes Against  Abstain  Broker Non-Votes
 29,621    35,466    1,527    200,431 

 

Proposal 4 was not approved.

 

 

 

 

 2 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ACLARION, INC.
     

July 21, 2025

By:/s/ John Lorbiecki
  Name: John Lorbiecki
  Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 3 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Aclarion Inc (ACON)

Reference

Frequently asked questions

When did Aclarion Inc file this 8-K?
Aclarion Inc (ACON) filed this Current Report (Form 8-K) with the SEC on July 21, 2025. The accession number assigned by EDGAR is 0001683168-25-005246.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Seven directors were elected for 2026. The reverse stock split was approved; the equity incentive plan amendment was not. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Aclarion Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Aclarion Inc has filed under CIK 1635077, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer